Hydroxytyrosol inhibits growth and cell proliferation and promotes high expression of sfrp4 in rat mammary tumours

Molecular Nutrition and Food Research

Volumn 55, Issue SUPPL. 1, 2011, Pages

  Granados Principal, Sergio ^a   Quiles, Jose L ^a   Ramirez Tortosa, Cesar ^b   Camacho Corencia, Pedro ^a   Sanchez Rovira, Pedro ^b   Vera Ramirez, Laura ^b   Ramirez Tortosa, Mcarmen ^a  

^a UNIVERSITY OF GRANADA   (Spain)

^b Pathology Department   (Spain)

Author keywords

Breast Cancer; DMBA; Hydroxytyrosol; Microarray; Rat

Indexed keywords

3,4-DIHYDROXYPHENYLETHANOL; ANTINEOPLASTIC AGENT; DRUG DERIVATIVE; HYDROXYTYROSOL; OLIVE OIL; ONCOPROTEIN; PHENETHYL ALCOHOL; SFRP4 PROTEIN, RAT; VEGETABLE OIL;

ANIMAL; APOPTOSIS; ARTICLE; BREAST TUMOR; CELL CYCLE; CELL PROLIFERATION; CHEMISTRY; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MICROARRAY ANALYSIS; PHYTOTHERAPY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BREAST NEOPLASMS; CELL CYCLE; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; MICROARRAY ANALYSIS; PHENYLETHYL ALCOHOL; PHYTOTHERAPY; PLANT OILS; PROTO-ONCOGENE PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

ANIMALIA; RATTUS;

EID: 79957820152     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201000220     Document Type: Article

References (35)

1. Salehi, F., Turner, M. C., Phillips, K. P., Wigle, D. T. et al., Review of the etiology of breast cancer with special attention to organochlorines as potential endocrine disruptors. J. Toxicol. Environ. Health B. Crit. Rev. 2008, 11, 276-300.
2. Medina, D., Chemical carcinogenesis of rat and mouse mammary glands. Breast Dis. 2007, 28, 63-68.
3. Shull, J. D., The rat oncogenome: comparative genetics and genomics of rat models of mammary carcinogenesis. Breast Dis. 2007, 28, 69-86.
4. Costa, I., Solanas, M., Escrich, E., Histopathologic characterization of mammary neoplastic lesions induced with 7, 12 dimethylbenz(alpha)anthracene in the rat: a comparative analysis with human breast tumours. Arch. Pathol. Lab. Med. 2002, 126, 915-927.
5. Russo, J., Gusterson, B. A., Rogers, A. E., Russo, I. H. et al., Comparative study of human and rat mammary tumourigenesis. Lab. Invest. 1990, 62, 244-278.
6. Kubatka, P., Ahlersová, E., Ahlers, I., Bojková, B. et al., Variability of mammary carcinogenesis induction in female Sprague-Dawley and Wistar:Han rats: the effects of season and age. Physiol. Res. 2002, 51, 633-640.
7. Russo, I. H., Russo, J., Mammary gland neoplasia in long-term rodent studies. Environ. Health Perspect. 1996, 104, 938-967.
8. Russo, J., Mailo, D., Hu, Y. F., Balogh, G. et al., Breast differentiation and its implication in cancer prevention. Clin. Cancer Res. 2005, 11, 931-936.
9. Costa, I., Moral, R., Solanas, M., Escrich, E., High-fat corn oil diet promotes the development of high histologic grade rat DMBA-induced mammary adenocarcinomas, while high olive oil diet does not. Breast Cancer Res. Treat. 2004, 86, 225-235.
10. Kumaraguruparan, R., Seshagiri, P. B., Hara, Y., Nagini, S., Chemoprevention of rat mammary carcinogenesis by black tea polyphenols: modulation of xenobiotic-metabolizing enzymes, oxidative stress, cell proliferation, apoptosis, and angiogenesis. Mol. Carcinog. 2007, 46, 797-806.
11. Quiles, J. L., Ramirez-Tortosa, M. C., Yaqoob, P. (Eds.), Olive Oil and Health, CABI Publishing, Oxford, 2006.
12. Granados-Principal, S., Quiles, J. L., Ramirez-Tortosa, C. L., Sanchez-Rovira, P., et al. Hydroxytyrosol: from laboratory investigations to future clinical trials. Nutr. Rev. 2010, 68, 191-206.
13. Escrich, E., Moral, R., García, G., Costa, I. et al., Identification of novel differentially expressed genes by the effect of a high-fat n-6 diet in experimental breast cancer. Mol. Carcinog. 2004, 40, 73-78.
14. Han, J., Talorete, T. P., Yamada, P., Isoda, H., Anti-proliferative and apoptotic effects of oleuropein and hydroxytyrosol on human breast cancer MCF-7 cells. Cytotechnology 2009, 59, 45-53.
15. Sirianni, R., Chimento, A., De Luca, A., Casaburi, I., Oleuropein and hydroxytyrosol inhibit MCF-7 breast cancer cell proliferation interfering with ERK1/2 activation. Mol. Nutr. Food Res. 2010, 54, 833-840.
16. Kovacheva, V. P., Davison, J. M., Mellott, T. J., Rogers, A. E. et al., Raising gestational choline intake alters gene expression in DMBA-evoked mammary tumours and prolongs survival. FASEB J. 2009, 23, 1054-1063.
17. Lo, C. Y., Hsieh, P. H., Chen, H. F., Su, H. M., A maternal high-fat diet during pregnancy in rats results in a greater risk of carcinogen-induced mammary tumours in the female offspring than exposure to a high-fat diet in postnatal life. Int. J. Cancer 2009, 125, 767-773.
18. Thomas, F. C., Taskar, K., Rudraraju, V., Goda, S. et al., Uptake of ANG1005, a novel paclitaxel derivative, through the blood-brain barrier into brain and experimental brain metastases of breast cancer. Pharm. Res. 2009, 26, 2486-2494.
19. Solanas, M., Hurtado, A., Costa, I., Moral, R. et al., Effects of a high olive oil diet on the clinical behavior and histopathological features of rat DMBA-induced mammary tumours compared with a high corn oil diet. Int. J. Oncol. 2002, 21, 745-753.
20. Karim, R., Tse, G., Putti, T., Scolyer, R., et al., The significance of the Wnt pathway in the pathology of human cancers. Pathology 2004, 36, 120-128.
21. Kawano, Y., Kypta, R., Secreted antagonists of the Wnt signalling pathway. J. Cell Sci. 2003, 116, 2627-2634.
22. Carmon, K. S., Loose, D. S., Secreted frizzled-related protein 4 regulates two Wnt7a signaling pathways and inhibits proliferation in endometrial cancer cells. Mol. Cancer Res. 2008, 6, 1017-1028.
23. Lacher, M. D., Siegenthaler, A., Jäger, R., Yan, X. et al., Role of DDC-4/sFRP-4, a secreted frizzled-related protein, at the onset of apoptosis in mammary involution. Cell Death Differ. 2003, 10, 528-538.
24. Mollet, J., Delahodde, A., Serre, V., Chretien, D. et al., CABC1 gene mutations cause ubiquinone deficiency with cerebellar ataxia and seizures. Am. J. Hum. Genet. 2008, 82, 623-630.
25. Granados-Principal, S., Quiles, J. L., Ramirez-Tortosa, C. L., Sanchez-Rovira, P., et al., New advances in molecular mechanisms and the prevention of adriamycin toxicity by antioxidant nutrients. Food Chem. Toxicol. 2010, 48, 1425-1438.
26. Quiles, J. L., Huertas, J. R., Battino, M., Mataix, J., et al., Antioxidant nutrients and adriamycin toxicity. Toxicology 2002, 180, 79-95.
27. Rose-John, S., Waetzig, G. H., Scheller, J., Grötzinger, J., et al. The IL-6/sIL-6R complex as a novel target for therapeutic approaches. Expert Opin. Ther. Targets 2007, 11, 613-624.
28. Chalaris, A., Rabe, B., Paliga, K., Lange, H. et al., Apoptosis is a natural stimulus of IL6R shedding and contributes to the proinflammatory trans-signaling function of neutrophils. Blood 2007, 110, 1748-1755.
29. Frémin, C., Meloche, S., From basic research to clinical development of MEK1/2 inhibitors for cancer therapy. J. Hematol. Oncol. 2010, 3, 8-19.
30. Arrigo, A. P., Simon, S., Gibert, B., Kretz-Remy, C. et al., Hsp27 (HspB1) and alphaB-crystallin (HspB5) as therapeutic targets. FEBS Lett. 2007, 581, 3665-3674.
31. Lin, D. I., Lessie, M. D., Gladden, A. B., Bassing, C. H. et al., Disruption of cyclin D1 nuclear export and proteolysis accelerates mammary carcinogenesis. Oncogene 2008, 27, 1231-1242.
32. Kim, W. Y., Sharpless, N. E., The regulation of INK4/ARF in cancer and aging. Cell 2006, 127, 265-275.
33. Blomen, V. A., Boonstra, J., Cell fate determination during G1 phase progression. Cell. Mol. Life Sci. 2007, 64, 3084-3104.
34. Gurzov, E. N., Bakiri, L., Alfaro, J. M., Wagner, E. F., et al., Targeting c-Jun and JunB proteins as potential anticancer cell therapy. Oncogene 2008, 27, 641-652.
35. Wu, M. X., Roles of the stress-induced gene IEX-1 in regulation of cell death and oncogenesis. Apoptosis 2003, 8, 11-18.